Innovating Works

SMERUD

Desconocido
REALMENT: Using real world big data from eHealth biobanks and national registries integrated with clinical t... SMERUD MEDICAL RESEARCH INTERNATIONAL AS participó en un H2020: H2020-SC1-BHC-2018-2020 Mental disorders represent one of the largest burdens for the European Health Care system, due to large number of patients and a lack of eff...
2021-01-29 - 2025-11-30 | Financiado
OligoGpivotalCF: A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide OligoG for cystic fibrosis SMERUD MEDICAL RESEARCH INTERNATIONAL AS participó en un H2020: H2020-SC1-2016-2017 The objective of the current proposal is to advance the orphan drug OligoG CF-5/20 (OligoG) through a pivotal phase IIb clinical trial, to e...
2017-12-05 - 2022-12-31 | Financiado
Soraprazan: Soraprazan a new regenerative therapy for Stargardt s disease SMERUD MEDICAL RESEARCH INTERNATIONAL AS participó en un H2020: H2020-SC1-2016-2017 Soraprazan – a new regenerative therapy for Stargardt’s disease Abnormal accumulation of lipofuscin in the RPE cells is a hallmark in Starg...
2017-11-15 - 2021-11-30 | Financiado
PREVENTROP: New approach to treatment of the blinding disease Retinopathy of Prematurity ROP SMERUD MEDICAL RESEARCH INTERNATIONAL AS participó en un FP7: The overall objective is to develop a novel preventative intervention for the blinding disease retinopathy of prematurity (ROP) and other co...
Financiado
CARDIMMUN: A new therapeutic antibody with a personalised medicine approach in cardiovascular disease SMERUD MEDICAL RESEARCH INTERNATIONAL AS participó en un FP7: The project, CARDIMMUN, aims to pursue development of the scientific findings from the FP6 project CVDImmune. Based on our patented discover...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.